China Wah Yan Healthcare (HK:0648) has released an update.
SoftMedx Healthcare Limited reported a challenging first half of 2024 with a revenue increase to HK$30,704,000 from last year’s HK$20,599,000 but faced a higher comprehensive loss of HK$6,093,000 compared to HK$3,401,000 in the previous year. Administrative expenses saw a significant decrease, but losses ballooned due to a steep drop in the fair value of financial assets. The company’s financial position reflects a net liability increase, suggesting a tightening financial situation amid rising costs and financial pressures.
For further insights into HK:0648 stock, check out TipRanks’ Stock Analysis page.
